61MA vs ACARIX: Side-by-Side Comparison
Compare MEDCAP AB SK-40 (61MA) and Acarix A/S (ACARIX) side by side: market cap EUR 695.02M vs SEK 303.41M. Financials, growth and model signals on Bullrun.
| Metric | 61MA | ACARIX |
|---|---|---|
| Company | MEDCAP AB SK-40 | Acarix A/S |
| Country / Exchange | Sweden · F | Sweden · ST |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
| Market cap | EUR 695.02M | SEK 303.41M |
| P/E ratio | 34.1 | — |
| Dividend yield | — | — |
| Valuation model | 40.0% overvalued | — |
| Revenue (latest FY) | SEK 1.81B | — |
| Revenue growth YoY | +13.8% | — |
| Net income | SEK 209.20M | — |
| Gross margin | — | — |
| Diluted EPS | 14.00 | — |